ADMA Biologics Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ADMA Nasdaq 2836 https://www.admabiologics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ADMA Biologics Inc

What Kind Of Investor Owns Most Of ADMA Biologics, Inc. (NASDAQ:ADMA)? - Sep 9th, 2019 12:54 pm
ADMA Biologics Announces Commercial Relaunch and its First Commercial Sales of BIVIGAM® - Aug 22nd, 2019 5:48 am
Breakeven On The Horizon For ADMA Biologics, Inc. (NASDAQ:ADMA) - Aug 8th, 2019 5:51 am
ADMA Biologics Reports Second Quarter and First Half 2019 Financial Results - Aug 8th, 2019 5:08 am
ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAM® and Nabi-HB® - Jul 8th, 2019 6:22 am
Did ADMA Biologics, Inc. (NASDAQ:ADMA) Insiders Buy Up More Shares? - Jun 27th, 2019 7:30 am
How Many ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Did Insiders Buy, In The Last Year? - Jun 27th, 2019 7:28 am
ADMA Biologics: Selloff Creates Buying Opportunity - Jun 18th, 2019 2:35 pm
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating ADMA Biologics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors - Jun 6th, 2019 5:25 am
ADMA Biologics Is De-Risked and Ready to Rise - May 30th, 2019 4:14 pm
ADMA Biologics to Present at Upcoming Investor Conferences - May 29th, 2019 5:11 am
These 3 Biotech Stocks Are Attracting Insider Buying - May 24th, 2019 8:30 am
ADMA Biologics Announces Closing of $51.75 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - May 21st, 2019 2:20 pm
Adma Biologics Inc (ADMA) President and CEO Adam S Grossman Bought $120,000 of Shares - May 21st, 2019 7:15 am
NeuBase Therapeutics Designates Industry Leaders to Board of Directors  - May 16th, 2019 6:00 am
ADMA Biologics Announces Proposed $45 Million Public Offering of Common Stock - May 15th, 2019 2:35 pm
FDA Approves Prior Approval Supplement for BIVIGAM® - May 10th, 2019 4:58 am
Adma Biologics: 1Q Earnings Snapshot - May 8th, 2019 5:03 pm
ADMA Biologics Reports First Quarter 2019 Financial Results - May 8th, 2019 2:18 pm